L
Lumy Biosciences
Carbon-negative synthesis of compounds via synthetic biology
About Lumy Biosciences
Founded in 2021, Lumy Biosciences is a synthetic biology company that leverages light-driven carbon dioxide (CO2) recycling to produce valuable compounds. The company's core technology utilizes photosynthetic autotrophic microorganisms, such as cyanobacteria, as cellular factories. Through rational design and multidimensional editing, Lumy Biosciences modifies the metabolism of these microorganisms to directly convert solar energy and CO2 into various platform compounds and natural products. This approach aims to create a "carbon-negative" production model, contrasting with traditional synthetic biology methods that often rely on sugar fermentation, which can have higher raw material costs and greenhouse gas emissions. The company's technology platform enables the rapid development of microbial strains and enhances synthesis efficiency.
Lumy Biosciences serves markets such as functional active ingredients, health nutrition, and sustainable agriculture. Its business model focuses on developing a pipeline of products, which includes compounds like cyanidin, colchicine, and demethoxycurcumin. In March 2023, the company announced it had raised nearly 100 million RMB in a Pre-A financing round. The stated purpose of these funds is to advance its product pipeline, build a carbon-negative synthesis facility, and expand its team.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 14.7/100
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | Mar 2023 | $14M | $55M | Vitalbridge Capital | ↗ |
| SEED✓Equity / VC | Sep 2021 | $0 | — | Innovation Angel Fund | — |
Growth signals
Latest recorded traffic for Lumy Biosciences is 50 monthly website visits.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Lumy Biosciences in its local ecosystem
The Lumy Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Innovation Angel Fund
Vitalbridge Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Lumy Biosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Lumy Biosciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.